SynthesisDiabetic medicine : a journal of the British Diabetic Association2019
Risk scores for type 2 diabetes mellitus in Latin America: a systematic review of population-based studies.
Synthesis in Diabetic medicine : a journal of the British Diabetic Association, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Prediction Models for Prognosis of Cervical Cancer: Systematic Review and Critical Appraisal.Frontiers in public health · 2021Pooled it
- FINDRISC in Latin America: a systematic review of diagnosis and prognosis models.BMJ open diabetes research & care · 2020Pooled it
- Risk scores for type 2 diabetes mellitus in Latin America: a systematic review of population-based studies.Diabetic medicine : a journal of the British Diabetic Association · 2019Pooled it
- BrDMrisc - Online Brazilian Risk Score for Incident Type 2 Diabetes - ELSA-Brasil Cohort.Revista de saude publica · 2026Article
- Awareness, treatment, and control of diabetes in South America: A systematic review and meta-analysis.Archives of endocrinology and metabolism · 2025Article
- [Diagnostic performance of the FINDRISC questionnaire to identify insulin resistance in adults].Revista medica del Instituto Mexicano del Seguro Social · 2023Observational
- Review
- Article
- A Newly Developed Diabetes Risk Index, Based on Lipoprotein Subfractions and Branched Chain Amino Acids, is Associated with Incident Type 2 Diabetes Mellitus in the PREVEND Cohort.Journal of clinical medicine · 2020Article
- Development and Validation of a New Diabetes Risk Score in Guyana.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2020Article
- The contribution of specific non-communicable diseases to the achievement of the Sustainable Development Goal 3.4 in Peru.PloS one · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
aimTo summarize the evidence on diabetes risk scores for Latin American populations.
methodsA systematic review was conducted (CRD42019122306) looking for diagnostic and prognostic models for type 2 diabetes mellitus among randomly selected adults in Latin America. Five databases (LILACS, Scopus, MEDLINE, Embase and Global Health) were searched. type 2 diabetes mellitus was defined using at least one blood biomarker and the reports needed to include information on the development and/or validation of a multivariable regression model. Risk of bias was assessed using the PROBAST guidelines.
resultsOf the 1500 reports identified, 11 were studied in detail and five were included in the qualitative analysis. Two reports were from Mexico, two from Peru and one from Brazil. The number of diabetes cases varied from 48 to 207 in the derivations models, and between 29 and 582 in the validation models. The most common predictors were age, waist circumference and family history of diabetes, and only one study used oral glucose tolerance test as the outcome. The discrimination performance across studies was ~ 70% (range: 66-72%) as per the area under the receiving-operator curve, the highest metric was always the negative predictive value. Sensitivity was always higher than specificity.
conclusionThere is no evidence to support the use of one risk score throughout Latin America. The development, validation and implementation of risk scores should be a research and public health priority in Latin America to improve type 2 diabetes mellitus screening and prevention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.